StreetInsider.com News Articles

Form S-3 Lifevantage Corp

Tue, 10 Mar 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260310/26139865.html

Form S-3 Lifevantage Corp

Tue, 10 Mar 2026 16:28:00 -0400

si-local-file:///var/storage/secattach/20260310/26139865.html

Form 4 Lifevantage Corp For: Feb 26 Filed by: Dayton Judd

Mon, 02 Mar 2026 18:44:00 -0400

si-local-file:///var/storage/secattach/20260302/26094453.html

Form 4 Lifevantage Corp For: Feb 26 Filed by: Dayton Judd

Mon, 02 Mar 2026 18:44:00 -0400

si-local-file:///var/storage/secattach/20260302/26094453.html

Form 4 Lifevantage Corp For: Feb 09 Filed by: Lewis Darwin

Wed, 11 Feb 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260211/25983973.html

Form 4 Lifevantage Corp For: Feb 09 Filed by: Lewis Darwin

Wed, 11 Feb 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260211/25983973.html

Form 4 Lifevantage Corp For: Feb 09 Filed by: Lewis Darwin

Wed, 11 Feb 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260211/25983974.html

Form 4 Lifevantage Corp For: Feb 09 Filed by: Lewis Darwin

Wed, 11 Feb 2026 16:32:00 -0400

si-local-file:///var/storage/secattach/20260211/25983974.html

Lifevantage Corporation (LFVN) PT Lowered to $5 at Lake Street Capital Markets

Thu, 05 Feb 2026 08:48:27 -0400

(Updated - February 5, 2026 8:48 AM EST)

Lake Street Capital Markets analyst Brooks O'Neil lowered the price target on Lifevantage Corporation (NASDAQ: LFVN) to $5.00 (from $12.00) while maintaining a Buy rating.

The analyst commented: "The company’s second quarter results and updated guidance were weaker than expected. While we anticipated significant y/y pressure given the tough comparison following last year’s MindBody GLP-1 launch, the revenue decline and the downward revision to FY26 guidance show underlying softness in the MindBody product beyond just comparison-related headwinds. Management acknowledged a more challenging competitive backdrop in weight loss and took an inventory obsolescence charge tied

Lifevantage Corporation (LFVN) PT Lowered to $5 at Lake Street Capital Markets

Thu, 05 Feb 2026 08:48:27 -0400

(Updated - February 5, 2026 8:48 AM EST)

Lake Street Capital Markets analyst Brooks O'Neil lowered the price target on Lifevantage Corporation (NASDAQ: LFVN) to $5.00 (from $12.00) while maintaining a Buy rating.

Form 8-K Lifevantage Corp For: Jan 30

Wed, 04 Feb 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260204/25946917.html

Form 8-K Lifevantage Corp For: Jan 30

Wed, 04 Feb 2026 16:07:00 -0400

si-local-file:///var/storage/secattach/20260204/25946917.html

Lifevantage (LFVN) Declares $0.045 Quarterly Dividend; 3.2% Yield

Wed, 04 Feb 2026 16:06:50 -0400

Lifevantage (NASDAQ: LFVN) declared a quarterly dividend of $0.045 per share, or $0.18 annualized.

The dividend will be payable on March 16, 2026, to stockholders of record on March 2, 2026, with an ex-dividend date of February 27, 2026.

The annual yield on the dividend is 3.2 percent.

For a dividend history and other dividend-related data on Lifevantage (LFVN) click here.

Lifevantage (LFVN) Reports In-Line Q2 EPS ; Offers Guidance

Wed, 04 Feb 2026 16:06:05 -0400

Lifevantage (NASDAQ: LFVN) reported Q2 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $48.9 million versus the consensus estimate of $54.84 million.

GUIDANCE:

Lifevantage sees FY2026 EPS of $0.60-$0.80, versus the consensus of $1.05. Lifevantage sees FY2026 revenue of $185-200 million, versus the consensus of $227.5 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.

Lifevantage (LFVN) Reports In-Line Q2 EPS ; Offers Guidance

Wed, 04 Feb 2026 16:06:05 -0400

Lifevantage (NASDAQ: LFVN) reported Q2 EPS of $0.15, in-line with the analyst estimate of $0.15. Revenue for the quarter came in at $48.9 million versus the consensus estimate of $54.84 million.

GUIDANCE:

Lifevantage sees FY2026 EPS of $0.60-$0.80, versus the consensus of $1.05. Lifevantage sees FY2026 revenue of $185-200 million, versus the consensus of $227.5 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.

Form 10-Q Lifevantage Corp For: Dec 31